- Home
- CRMD vs BRSP Comparison
CRMD vs BRSP Comparison
Compare CRMD & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- BRSP
- Stock Information
- Founded
- CRMD 2006
- BRSP 2017
- Country
- CRMD United States
- BRSP United States
- Employees
- CRMD N/A
- BRSP N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- BRSP Real Estate Investment Trusts
- Sector
- CRMD Health Care
- BRSP Real Estate
- Exchange
- CRMD Nasdaq
- BRSP Nasdaq
- Market Cap
- CRMD 865.2M
- BRSP 764.4M
- IPO Year
- CRMD 2010
- BRSP 2018
- Fundamental
- Price
- CRMD $11.20
- BRSP $5.15
- Analyst Decision
- CRMD Strong Buy
- BRSP Buy
- Analyst Count
- CRMD 8
- BRSP 3
- Target Price
- CRMD $17.57
- BRSP $6.00
- AVG Volume (30 Days)
- CRMD 2.9M
- BRSP 662.9K
- Earning Date
- CRMD 10-29-2025
- BRSP 10-28-2025
- Dividend Yield
- CRMD N/A
- BRSP 12.50%
- EPS Growth
- CRMD N/A
- BRSP N/A
- EPS
- CRMD 0.79
- BRSP N/A
- Revenue
- CRMD $121,484,498.00
- BRSP $335,107,000.00
- Revenue This Year
- CRMD $446.49
- BRSP N/A
- Revenue Next Year
- CRMD $59.96
- BRSP $6.74
- P/E Ratio
- CRMD $14.61
- BRSP N/A
- Revenue Growth
- CRMD 14970.29
- BRSP N/A
- 52 Week Low
- CRMD $5.60
- BRSP $4.16
- 52 Week High
- CRMD $17.43
- BRSP $6.45
- Technical
- Relative Strength Index (RSI)
- CRMD 41.16
- BRSP 25.59
- Support Level
- CRMD $10.95
- BRSP $5.34
- Resistance Level
- CRMD $11.71
- BRSP $5.51
- Average True Range (ATR)
- CRMD 0.53
- BRSP 0.11
- MACD
- CRMD 0.01
- BRSP -0.07
- Stochastic Oscillator
- CRMD 12.69
- BRSP 9.87
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.